| +380 44 495-10-14 |
rus | eng
|
|
SaizenATC code: HO1 A
Active ingredient: Recombinant human growth hormone produced by genetically engineered mammalian cells.
International name: Somatotropin
Pharmacotherapeutic group
Anterior pituitary lobe hormones and analogues Indications: Growth failure caused by decreased or absent secretion of endogenous growth hormone. Growth failure in girls with gonadal dysgenesis (Turner Syndrome). Growth failure in prepubertal children due to chronic renal failure (CRF). Replacement therapy in adults with pronounced growth hormone deficiency. Saizen 8 mg click.easy Registration status: UA/1567/01/02; expiry date: 15.01.2013 Dosage: 8 mg/vial Packaging: 1 vial with powder + 1 cartridge + 1 device for reconstitution + 1 plungers Shelf-life (months): 36 (t +2 - +8 C) Saizen 1,33 mg Registration status: UA/1567/01/01; expiry date: 07.07.2014 Dosage: 1,33 mg/vial Packaging: 1 vial with powder + 1 ampoule with solvent Shelf-life (months): 24 (t +2 - +8 C) |
29.05.2010
21.05.2010
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sona-Pharm LLC
Ukraine, 03680 Kyiv Mykoly Grinchenka Str., 4 Теl: +38 044 495 10 14 Fax: +38 044 495 10 15 office@sona-pharm.com.ua |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||